Clinical trial
Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)
NCT00124397 · University of Southern Denmark, Other · Completed
Key facts
| NCT number | NCT00124397 |
|---|---|
| Title | Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study) |
| Official title | Effect of High Dose Statin Therapy on Endothelial Function in Patients With Type 2 Diabetes Mellitus Without CAD |
| Lead sponsor | University of Southern Denmark, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 186 |
| Start date | Jul 1, 2001 |
| Completion | Dec 1, 2004 |
| First posted | Jul 27, 2005 |
| Last update posted | Aug 5, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: